Literature DB >> 4885753

Biochemical and clinical aspects of the porphyrias.

R D Levere, A Kappas.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4885753     DOI： 10.1016/s0065-2423(08)60058-x

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


× No keyword cloud information.
  3 in total

1.  The influence of postnatal development on drug-induced hepatic porphyria and the synthesis of cytochrome P-450. A biochemical and morphological study.

Authors:  C S Song; H L Moses; A S Rosenthal; N A Gelb; A Kappas
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

2.  Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria.

Authors:  H L Bradlow; P N Gillette; T F Gallagher; A Kappas
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

3.  Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria.

Authors:  A Kappas; H L Bradlow; P N Gillette; T F Gallagher
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.